New Immunotherapies Bring Hope to Patients with Rare Liver Cancers Tina lived a healthy lifestyle and wanted to live as long as she could. A rare cancer diagnosis called cholangiocarcinoma threatened her dreams. Tina’s oncologist recommended a clinical trial that combined chemotherapy and immunotherapy. She details how the treatment extended her life and why patients must advocate for themselves. Leer más: Navegación de entradas The CRISPR Revolution: How Genomic Engineering is Transforming Cancer Immunotherapy Leer historia CICON Landing Page Draft Leer historia